These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38715652)

  • 41. Genotype and brain pathology phenotype in children with tuberous sclerosis complex.
    Overwater IE; Swenker R; van der Ende EL; Hanemaayer KB; Hoogeveen-Westerveld M; van Eeghen AM; Lequin MH; van den Ouweland AM; Moll HA; Nellist M; de Wit MY
    Eur J Hum Genet; 2016 Dec; 24(12):1688-1695. PubMed ID: 27406250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex.
    Franz DN
    Biologics; 2013; 7():211-21. PubMed ID: 24143074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling Neurodevelopmental Deficits in Tuberous Sclerosis Complex with Stem Cell Derived Neural Precursors and Neurons.
    Sundberg M; Sahin M
    Adv Neurobiol; 2020; 25():1-31. PubMed ID: 32578142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotype/phenotype correlation in 123 Chinese patients with Tuberous Sclerosis Complex.
    Ng SY; Luk HM; Hau EW; Cheng SS; Yu KP; Ho S; Mok MT; Lo IF
    Eur J Med Genet; 2022 Oct; 65(10):104573. PubMed ID: 35918040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two different genetic etiologies for tuberous sclerosis complex (TSC) in a single family.
    Mowrey K; Koenig MK; Szabo CA; Samuels J; Mulligan S; Pearson DA; Northrup H
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1296. PubMed ID: 32383331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotype and Phenotype Analysis of Chinese Children With Tuberous Sclerosis Complex: A Pediatric Cohort Study.
    Ding Y; Wang J; Zhou S; Zhou Y; Zhang L; Yu L; Wang Y
    Front Genet; 2020; 11():204. PubMed ID: 32211034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tuberous sclerosis complex without tubers and subependymal nodules: a phenotype-genotype study.
    Boronat S; Shaaya EA; Doherty CM; Caruso P; Thiele EA
    Clin Genet; 2014 Aug; 86(2):149-54. PubMed ID: 23909698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported.
    Niida Y; Wakisaka A; Tsuji T; Yamada H; Kuroda M; Mitani Y; Okumura A; Yokoi A
    J Hum Genet; 2013 Apr; 58(4):216-25. PubMed ID: 23389244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy.
    Wheless JW
    Epilepsy Behav Case Rep; 2015; 4():63-6. PubMed ID: 26543807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropsychiatric manifestations of tuberous sclerosis in a young man in a psychiatric hospital in Botswana: a case report.
    Chabalala WT; Bojosi K; Maphane T; Olashore AA
    J Int Med Res; 2024 Jan; 52(1):3000605231223450. PubMed ID: 38217425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging of tuberous sclerosis complex: a pictorial review.
    von Ranke FM; Faria IM; Zanetti G; Hochhegger B; Souza AS; Marchiori E
    Radiol Bras; 2017; 50(1):48-54. PubMed ID: 28298732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stochastic model of Tsc1 lesions in mouse brain.
    Prabhakar S; Goto J; Zhang X; Sena-Esteves M; Bronson R; Brockmann J; Gianni D; Wojtkiewicz GR; Chen JW; Stemmer-Rachamimov A; Kwiatkowski DJ; Breakefield XO
    PLoS One; 2013; 8(5):e64224. PubMed ID: 23696872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.
    Boer K; Troost D; Jansen F; Nellist M; van den Ouweland AM; Geurts JJ; Spliet WG; Crino P; Aronica E
    Neuropathology; 2008 Dec; 28(6):577-90. PubMed ID: 18410267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tuberous Sclerosis: A Case Report and Review of the Literature.
    Dzefi-Tettey K; Edzie EK; Gorleku P; Piersson AD; Cudjoe O
    Cureus; 2021 Jan; 13(1):e12481. PubMed ID: 33552794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain lesions in tuberous sclerosis complex. Review.
    Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
    Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nursing implications for the lifelong management of tuberous sclerosis complex.
    Agricola K; Tudor C; Krueger D; Franz DN
    J Neurosci Nurs; 2013 Aug; 45(4):226-42. PubMed ID: 23812052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
    Kim WS
    Korean J Pediatr; 2011 Jun; 54(6):241-5. PubMed ID: 21949518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.